UniFirst Corporation (UNF) Drops 2.22% After Earnings, EPS Below Consensus, Revenue Tops Expectations

2026-01-07 · Stocks · QuoteReporter

Post Earning Analysis

UniFirst Corporation (UNF) Drops 2.22% After Earnings, EPS Below Consensus, Revenue Tops Expectations

UniFirst Corp., founded in 1936 by Aldo Croatti and headquartered in Wilmington, MA, specializes in providing workplace uniforms and protective work wear. The company operates through several segments including U.S. and Canadian Rental and Cleaning, Manufacturing, Specialty Garments, and First Aid. UniFirst designs, manufactures, rents, and maintains a range of uniforms and safety products, catering to diverse industry needs.

UniFirst Corporation, a leader in the uniform rental and facility services industry, has recently reaffirmed its outlook for Fiscal Year 2026 and reported first-quarter results that exceeded estimates. On January 7, 2026, the company announced its financial results for the first quarter, highlighting strong performance that surpassed analyst expectations. This follows their fourth quarter of Calendar Year 2025 sales, which also topped estimates, indicating a consistent upward trend in the company’s financial performance.

These positive financial results are significant as they may influence investor confidence and could potentially lead to an increase in stock value due to the company’s demonstrated ability to meet and exceed financial targets. The reaffirmation of the FY26 outlook suggests stability and continued growth prospects for UniFirst, making it an attractive option for potential investors. This series of positive reports could contribute to a favorable market response, enhancing UniFirst’s reputation in the financial markets and among its industry peers.

The current price of the stock stands at $198.77, reflecting a significant decline of 2.22% today. This price positions the stock below its recent weekly high of $204.65 by approximately 2.87% and above the weekly low of $186.61 by 6.52%. When considering broader timeframes, the stock is currently 17.82% below the 52-week and year-to-date highs of $241.87, yet it has risen by 34.89% from the 52-week and year-to-date lows of $147.36.

The moving averages indicate a bullish trend in the medium to longer term, with the current price exceeding the 20-day, 50-day, and 200-day moving averages by 5.6%, 15.22%, and 13.91%, respectively. This suggests sustained upward momentum over these periods.

From a technical analysis perspective, the Relative Strength Index (RSI) at 65.03 indicates that the stock is approaching overbought territory, which could signal a potential pullback or stabilization in price. The MACD value of 7.54 supports this bullish trend, suggesting that the upward momentum has been strong in recent trading sessions. Overall, the stock exhibits a generally positive trend with potential caution advised due to the near overbought conditions.

UniFirst Corporation (NYSE: UNF), based in Wilmington, MA, announced its financial results for the first quarter of fiscal 2026, ending November 29, 2025. The company reported a 2.7% increase in consolidated revenues, reaching $621.3 million, up from $604.9 million in the same quarter the previous year. Despite this growth, UniFirst faced challenges in profitability with a decrease in operating margin to 7.3% from 9.2% and a decline in net income to $34.4 million from $43.1 million year-over-year. Diluted EPS also fell to $1.89 from $2.31.

The company’s adjusted EBITDA margin decreased to 13.3% from 15.5%. The quarterly tax rate rose to 26.9% from 25.6%. Despite these downward trends, UniFirst highlighted organic growth of 2.4%, primarily driven by new customer acquisitions and improved retention rates. Cash reserves were strong at $129.5 million, with no long-term debt.

UniFirst repurchased $31.7 million of its common stock and declared a quarterly dividend of $0.365 per share, continuing its record of dividend growth. For fiscal 2026, the company projects consolidated revenues between $2.475 billion and $2.495 billion and anticipates a fully diluted EPS range of $6.58 to $6.98, inclusive of an estimated $7.0 million in costs related to strategic initiatives.

Earnings Trend Table

The earnings per share (EPS) data over the observed quarters shows a mix of surpassing and falling short of estimates, with notable fluctuations in both the magnitude of surprises and the EPS values themselves. Starting from the most recent quarter in 2026, the company reported an EPS of 1.98, which was below the estimate by 3.41%. This decline is a shift from the previous positive surprise trends observed in five out of the seven preceding quarters.

Notably, the quarters ending in January 2025 and October 2024 experienced significant positive surprises of 8.11% and 22.18%, respectively, suggesting strong performance during these periods. Similarly, the June 2024 quarter also saw a considerable positive surprise of 20.20%. These quarters indicate periods of robust earnings exceeding analyst expectations.

Conversely, the quarter ending in March 2024 marked a significant downturn, with the reported EPS falling 14.39% short of expectations, which was the only instance of a substantial negative surprise in this dataset. This suggests a period of underperformance relative to market expectations.

Overall, the trend shows generally positive surprises with occasional dips. The data reflects a company capable of exceeding expectations but also highlights vulnerabilities during specific periods. The variability in surprise percentage and the alternating pattern of over and underperformance could be indicative of external market factors or internal operational impacts influencing the company’s quarterly financial outcomes.

Dividend Payments Table

The data indicates a clear trend in the dividends over the observed periods from March 2024 to December 2025. Initially, dividends were maintained at 0.33 for all quarters of 2024. This consistency suggests a period of stability in the company’s dividend policy during that year. Starting from the last quarter of 2024, there was a noticeable increase in dividends to 0.35, which persisted through the first three quarters of 2025. This increment reflects a positive adjustment in the company’s dividend distribution, possibly indicative of improved financial health or a strategic decision to return more capital to shareholders.

The most recent data point from December 2025 shows a further increase in the dividend to 0.365. This incremental rise, although modest, continues the upward trend in dividend payouts, suggesting ongoing confidence in the company’s financial stability and a commitment to enhancing shareholder value. This progression might be seen positively by investors looking for steady growth in dividend income.

The most recent rating changes for the stock in consideration reveal a trend towards a more cautious stance from investment analysts.

1. JP Morgan – July 14, 2025: JP Morgan resumed coverage with an ‘Underweight’ rating, assigning a target price of $175. This suggests that JP Morgan analysts anticipate the stock to underperform relative to the broader market or its sector peers over the upcoming period. This rating, particularly being a resumption, indicates a reassessment of the stock potentially due to recent developments or market conditions that could impact the company’s future performance.

2. Barclays – April 4, 2025: Barclays downgraded the stock from ‘Equal Weight’ to ‘Underweight’ and set a target price of $152. This significant adjustment reflects a bearish outlook from Barclays, suggesting that the stock’s previous performance or market conditions no longer justify a neutral stance. The lowered target price points to expected downward pressure on the stock’s value.

3. Robert W. Baird – January 4, 2024: The firm downgraded the stock from ‘Outperform’ to ‘Neutral’ with a target price of $185. This change indicates a shift from expecting the stock to outperform the market or its sector to a stance where it is expected to perform in line with the market. The relatively higher target price compared to later ratings suggests that while the optimism has decreased, the firm still sees some positive attributes.

4. Barclays – October 6, 2023: Barclays initiated coverage of the stock with an ‘Equal Weight’ rating and a target price of $160. This initiation likely reflects a balanced view of the stock’s prospects, weighing its potential risks and rewards. The target price set during this initiation provided a baseline from which the subsequent downgrade was a significant adjustment.

Overall, these changes depict a trajectory of diminishing confidence among analysts regarding the stock’s future market performance, with recent assessments leaning towards underperformance.

As of the latest available data, the stock is trading at $198.77. This price is above the average target price set by analysts, which suggests a potential overvaluation according to recent analyst assessments. Notably, the target prices range from $152 to $185, with the highest being from Robert W. Baird at $185 and the lowest from Barclays at $152 after a downgrade from Equal Weight to Underweight.

The ratings from various financial institutions indicate a cautious or negative outlook on the stock’s future performance. For instance, JP Morgan resumed coverage with an ‘Underweight’ rating and a target price of $175, indicating expectations of underperformance relative to the market or sector. Similarly, Barclays’ downgrade to ‘Underweight’ with a revised target price of $152 points towards significant concerns about the stock’s valuation or future earnings potential.

Overall, the consensus among these analysts suggests a bearish outlook, with expectations of a decrease in the stock’s price in the medium term. This analysis should be considered by investors who are evaluating the potential risks and returns of investing in this stock.

Disclaimer: The information provided here is for educational and informational purposes only and should not be interpreted as financial advice, investment recommendations, or trading guidance. Markets involve risk, and past performance is not indicative of future results. You should always conduct your own research and consult with a qualified financial advisor before making any investment decisions. By acting, you accept full responsibility for your choices.